Superior mesenteric venous thrombosis

Kaminsky, Matt; Hochman, David

doi:10.1503/cmaj.092134

Cited by 4 publications

(3 citation statements)

References 2 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“… 20 The typical duration of anticoagulation treatment is 6-12 months. 3 The immediate initiation of anticoagulation with low-molecular-weight heparin and a subsequent 6-month course of warfarin proved to be successful in the present case.…”

Section: Discussionsupporting

confidence: 50%

See 1 more Smart Citation

Superior Mesenteric Vein Thrombosis as an Early Presentation of Myelodysplastic Syndrome: A Case Report

et al. 2014

View full text Add to dashboard Cite

Mesenteric venous thrombosis (MVT) is a serious condition due to its potential association with mesenteric ischemia and infarction of the small bowel. Symptoms of MVT are often vague, making accurate diagnosis and sufficient treatment difficult. However, increased awareness and new imaging modalities for this condition have improved outcomes for patients with MVT. Treatment includes anticoagulation, transcatheter therapy, and surgery. In the present report, we describe the case study of a 62-year-old woman with a presenting diagnosis of superior MVT, who was finally diagnosed with myelodysplastic syndrome. The superior MVT spontaneously dissolved after the patient underwent 6 months of systemic anticoagulation therapy. Invasive surgery or bowel resection was not required.

show abstract

Section: Discussionsupporting

confidence: 50%

“…Acute MVT is a rare but potentially fatal condition, with a mortality rate of 20-30%. 3 , 4 However, diagnosis of this condition is difficult because the symptoms are nonspecific. The most commonly reported symptom is abdominal pain.…”

Section: Discussionmentioning

confidence: 99%

Superior Mesenteric Vein Thrombosis as an Early Presentation of Myelodysplastic Syndrome: A Case Report

et al. 2014

View full text Add to dashboard Cite

show abstract

“…Acute mesenteric venous thrombosis is a rare but potentially fatal condition with a mortality rate of 20–30% [ 3 ]. Like all thrombotic events, the formation of mesenteric venous thrombosis is a result of Virchow’s Triad (Endothelial injury, stasis of flow and hypercoagulability).…”

Section: Introductionmentioning

confidence: 99%

Intestinal ischemia secondary to superior mesenteric venous thrombosis—A case report

Cui¹,

Kirkby²

2018

International Journal of Surgery Case Reports

View full text Add to dashboard Cite

show abstract

Superior mesenteric vein thrombosis in a patient with primary focal segmental glomerulosclerosis

Somaili

Wang

Almansour

et al. 2021

Medicine: Case Reports and Study Protocols

View full text Add to dashboard Cite

Introduction: Nephrotic syndrome creates a hypercoagulable state that predisposes patients to venous thromboembolism. Mesenteric vein thrombosis associated with minimal change disease and membranous nephropathy has rarely been reported. Few cases of mesenteric vein thrombosis have been reported in some types of nephrotic syndrome; however, isolated mesenteric vein thrombosis has not been previously reported in adults with nephrotic syndrome due to focal segmental glomerulosclerosis. Patient concern: A 19-year-old man with biopsy-proven primary focal segmental glomerulosclerosis was in partial disease remission when he presented with postprandial abdominal pain four months after starting prednisone therapy. Diagnosis: Abdominal computed tomography revealed subacute superior mesenteric vein thrombosis complicated by distal ileum ischemia. Intervention: The patient was treated with low-molecular-weight heparin and bridged with warfarin. Prednisone therapy was continued for the underlying nephrotic syndrome. Outcomes: The patient's symptoms improved with conservative management. He continued to be asymptomatic at subsequent follow-up visits, with no reported complications or medication side effects. Conclusion: This unique case of superior mesenteric vein thrombosis in an adult with nephrotic syndrome due to primary focal segmental glomerulosclerosis in partial remission diagnosed on computed tomography was treated conservatively with anticoagulation therapy. The findings in this case suggest that in patients with nephrotic syndrome, hypercoagulability may extend beyond the acute stage of the disease despite treatment.

show abstract

Superior mesenteric venous thrombosis

Cited by 4 publications

References 2 publications

Superior Mesenteric Vein Thrombosis as an Early Presentation of Myelodysplastic Syndrome: A Case Report

Superior Mesenteric Vein Thrombosis as an Early Presentation of Myelodysplastic Syndrome: A Case Report

Intestinal ischemia secondary to superior mesenteric venous thrombosis—A case report

Superior mesenteric vein thrombosis in a patient with primary focal segmental glomerulosclerosis

Contact Info

Product

Resources

About